Barclays Initiates Coverage of Celanese at Equal-Weight
Fintel reports that on October 13, 2026, Barclays initiated coverage of Celanese (NYSE:CE) (LSE:0HUR) with a Equal-Weight recommendation.
On the same day, October 13, 2026, RBC Capital maintained its Sector Perform rating on Celanese, with the rating remaining Sector Perform. Prior to these actions, on September 30, 2026, Citigroup maintained its Buy rating on the stock.
Prior to the rating action, Celanese closed at $44.56 on October 12, 2026. This latest close represents a price change of -2.13% over one week, relative to a baseline close of $45.53 on October 5, 2026. Over a one-month period, the stock experienced a price change of -3.32% from a baseline close of $46.09 on September 11, 2026.
As of October 2, 2026, the current consensus target mean for Celanese was $63.22, with a median target of $61.20. This mean target implies a change of +41.87% from the stock's recent valuation. The prior consensus target mean was $64.24 as of September 15, 2026, representing a consensus target revision of -1.59%. Separately, the consensus recommendation breakdown for the period ending September 1, 2026, consisted of 8 strong buy, 9 buy, 8 hold, and 1 sell recommendations. This aggregate recommendation profile represents 65.4% positive, 30.8% hold, and 3.8% negative ratings out of 26 total recommendations.
Celanese reported its latest quarterly earnings on August 4, 2026, posting an actual EPS of 2.45, which exceeded the estimated EPS of 2.2984 by a surprise of +6.60%. The company generated actual revenue of $2,752,000,000.00, compared to the estimated revenue of $2,827,832,513.00. The company's upcoming earnings announcement is scheduled for November 2, 2026, during the amc session. Celanese Corporation is a global chemical and specialty materials company based in the United States. It operates primarily in the chemicals and advanced materials sectors, focusing on the production of acetyl products and engineered polymers. Its key products, including acetic acid and vinyl acetate monomers, are critical components in coatings, adhesives, and solvents, impacting a wide range of industries from automotive to pharmaceuticals.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| October 13, 2026 | Barclays | Equal-Weight | initiated coverage | |
| October 13, 2026 | RBC Capital | Sector Perform | Sector Perform | maintained |
| September 30, 2026 | Citigroup | Buy | Buy | maintained |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.